Short Interest in bioAffinity Technologies, Inc. (NASDAQ:BIAF) Drops By 35.8%

bioAffinity Technologies, Inc. (NASDAQ:BIAF) saw a significant drop in short interest in December. As of December 31st, there was short interest totalling 114,000 shares, a drop of 35.8% from the December 15th total of 177,500 shares. Based on an average daily trading volume, of 150,600 shares, the short-interest ratio is currently 0.8 days. Currently, 1.2% of the shares of the stock are sold short.

bioAffinity Technologies Price Performance

Shares of BIAF traded down $0.05 on Friday, hitting $0.68. The company’s stock had a trading volume of 167,251 shares, compared to its average volume of 393,805. The company has a market capitalization of $10.52 million, a PE ratio of -0.82 and a beta of 2.98. bioAffinity Technologies has a fifty-two week low of $0.66 and a fifty-two week high of $3.62. The company has a 50 day moving average price of $1.04 and a 200 day moving average price of $1.59. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.02 and a quick ratio of 1.01.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.